CRNX — Crinetics Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Crinetics Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	334	334	559	1,354	1,028
Net Total Accounts Receivable
Net Total Receivables	1.48	2.29	9.1	8.39	0.592
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	345	345	574	1,375	1,048
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.72	4.99	57.4	55.6	54.8
Long Term Investments
Other Long Term Assets
Total Assets	351	352	635	1,435	1,126
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16	27.7	43.9	59.7	85.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.1	35.8	96.2	110	134
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	332	316	539	1,325	992
Total Liabilities & Shareholders' Equity	351	352	635	1,435	1,126
Total Common Shares Outstanding